Superficial bladder cancer
Author(s)
Bibliographic Information
Superficial bladder cancer
ISIS Medical Media, 1997
Available at 7 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
This account of the etiology, diagnosis, management and future trends in bladder cancer starts by addressing epidemiological questions, before going on to discuss the molecular factors influencing carcinoma of the bladder. Also covered in Superficial Bladder Cancer are disease and prognosis issues, and new therapies, including biological response modifier, photodynamic treatments and new drugs. The authors aim to address the controversial issues surrounding this topic and provide a consensus of opinion.
Table of Contents
1. Epidemiology of bladder cancer 2. Bladder cancer as a molecular disease 3. Current issues in the pathology of superficial bladder cancer 4. Natural history and prognosis of 'untreated' and 'treated' superficial bladder cancer 5. Prognostic factors: back to the future 6. Towards a better knowledge of bladder cancer 7. Rationale and principles of intravesical therapy 8. Methodology in superficial bladder cancer trials 9. Objective response criteria to intravesical chemotherapy 10. Overview on Doxorubicin and Epirubicin 11. Overview on Mitomycin C (MMC) 12. Overview on Bacillus Calmette-Guerin 13. The use of biological modifiers in the treatment of superficial bladder cancer 14. Intravesical chemotherapy versus immunotherapy 15. Photodynamic therapy of bladder carcinoma 16. Unresponsive superficial bladder cancer 17. Bladder cancer and automated nuclear morphological grading 18. The management of TI bladder tumor: conservative therapy 19. The management of TI tumor: the case for aggressive treatment 20. Carcinoma in situ 21. Follow-up of patients with 'superficial' transitional cell carcinoma of the bladder: time to reflect 22. Satisfaction with life during intravesical immuno-therapy with Bacillus Calmette-Guerin - a pilot study
by "Nielsen BookData"